Perrigo Co. Ltd.
- BID
9.18
- ASK
9.194
- 1,089 Units2,175 Units
- 07/21, 21:59:59 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
59.99%
Market Cap
1.27 Bil.
P/E Ratio
0.00
Dividend Yield
8.33 %
Earnings per Share
-9.12 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 9.146 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:56:28 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 9.276 | 9.002 |
| PREV. DAY'S PRICE | 9.274 | (07/20) |
| CHANGE DAY BEFORE | -0.13 | -1.38 % |
| 52 WEEK HIGH / LOW | 24.31 (07/28) | 7.92 (03/23) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.09 | -1.16 | -9.12 | 1.84 | 2.08 |
DIVIDENDS PER SHARE | 1.01 | 1.02 | 1.03 | 1.01 | 1.03 |
DIVIDEND YIELD IN % | 3.39 % | 4.29 % | 8.33 % | - | - |
DIVIDEND GROWTH IN % | 2.13 % | 1.04 % | 0.75 % | - | - |
PRICE - EARNINGS RATIO | - | - | 5.06(e) | 5.08 | 4.51 |
PRICE - BOOK RATIO | 0.91 | 0.81 | 0.65 | - | - |
PRICE - SALES RATIO | 0.94 | 0.81 | 0.45 | - | - |
PRICE - CASH FLOW RATIO | 10.74 | 9.73 | 8.08 | - | - |
Master Data
| WKN | A1XAEY |
| ISIN | IE00BGH1M568 |
| SYMBOL | PIG |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Perrigo |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 138.37 Mil. |
| MARKET CAPITALISATION | 1.27 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 4.53 % | 4.39 % | -9.12 % | -28.05 % | -59.99 % | -70.09 % | -75.47 % | -20.60 % |
| HIGH | 9.69 | 10.10 | 10.51 | 12.89 | 24.31 | 36.32 | 42.51 | 13.09 |
| LOW | 8.60 | 8.26 | 8.26 | 7.92 | 7.92 | 7.92 | 7.92 | 7.92 |
Dividende
pro Aktie
Company profile
Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
Structured products for Perrigo Co. Ltd.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.